Florida Hospital Cancer Institute Community Clinical Oncology Program

描述(由申请人提供)：基督复临安息日会医院系统在10个州经营37家医院。在佛罗里达州中部，佛罗里达医院系统有六个医院园区(将参与FHCI-CCOP申请)在一个许可证下收费。佛罗里达七大医院系统的旗舰医院是佛罗里达南部医院(FH)，位于奥兰多，奥兰治县。佛罗里达南方医院(FH)提供全方位的服务，包括内科肿瘤科、放射肿瘤科、儿科肿瘤科、骨髓移植、外科肿瘤科、神经肿瘤科和妇科肿瘤科。佛罗里达州中部的其他五家医院位于邻近的奥西洛和塞米诺尔县。第七家医院佛罗里达医院纪念医疗中心(MMC)位于沃卢西亚县。MMC也归基督复临安息日健康公司所有，但有单独的许可证。佛罗里达医院癌症研究所(FHCI)的成立是为了协调FH系统中的所有癌症活动。Lee Zehngebot博士领导FHCI的临床活动已有20多年。Zehngebot博士是FHCI内一项成功的临床试验的设计师。该项目获得了国家级奖项和认可。FHCl的研究部门在合作小组和药物试验方面都有很好的历史。去年，在我们为过渡到CCOP计划做准备时，FHCI注册了相当于56个治疗学分和54.8个癌症控制学分的CCOP学分，其中大部分学分是从2011年1月开始积累的。此外，FHCl的集水区包括超过40%的西班牙裔人口和20%的非裔美国人的县。虽然肿瘤登记数据只显示11%的西班牙裔和8.5%的非裔美国人，但临床试验的登记人数显示13%的西班牙裔和10%的非裔美国人。FH系统中的上述六家医院和另一家MMC希望成为CCOP。我们将CCOP奖项视为进一步整合我们的癌症临床试验和研究计划的基石。CCOP的授予将使FHCI能够扩大其在佛罗里达州中部社区的地理和范围的临床试验努力。

DESCRIPTION (provided by applicant): The Seventh Day Adventist Hospital System operates 37 hospitals in 10 states. In Central Florida, the Florida Hospital System has six hospital campuses (that will be participating in the FHCI-CCOP application) that bill under one license. The flagship hospital of the seven Florida Hospital System is Florida Hospital South (FH) located in Orlando, Orange County. Florida Hospital South (FH) offers a full array of services including medical oncology, radiation oncology, pediatric oncology, bone marrow transplantation, surgical oncology, neuro-oncology, and gynecologic oncology. The other five hospitals in Central Florida are located in the neighboring Oscelo and Seminole counties. A seventh hospital Florida Hospital Memorial Medical Center (MMC) is located in Volusia County. MMC is also owned by Adventist Health, but falls under a separate license. The Florida Hospital Cancer Institute (FHCI) was created to coordinate all of the cancer activities in the FH System. Dr. Lee Zehngebot has been leading the clinical activities of the FHCI for over 20 years. Dr. Zehngebot has been the architect of a successful clinical trial within the FHCI. This program has received national awards and recognition. The FHCl's Research department has a strong history of both cooperative group and pharmaceutical trials. Over the last year as we prepared for the transition to a CCOP program, FHCI enrolled CCOP credit equivalents of 56 treatment credits and 54.8 cancer control credits, with the majority of credits accrued since January 2011. In addition, FHCl's catchment area includes counties with over 40% Hispanic population and 20 % African American. While the tumor registry data only shows 11 % Hispanic and 8.5 % African American, enrollment to clinical trials shows 13% Hispanic and 10% African American. The above six hospitals in the FH System along with another MMC wish to become a CCOP. We view a CCOP award as a cornerstone to further integrate our cancer clinical trials and research programs. A CCOP award will allow FHCI to expand its clinical trials efforts in both geography and scope in the central Florida community.